SCHEMBL17023117

SCHEMBL17023117

CCN1CCN(Cc2cnc3c(OC(=O)Nc4ccccn4)ccc(-c4c(Cl)c(OC)cc(OC)c4Cl)c3n2)CC1

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 19/20 0.63
FGFR1 P11362 1/20 0.41
FGFR2 P21802 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1126276 0.89 FGFR3 (0.77) FGFR3
SCHEMBL17023087 0.85 FGFR3 (0.81) FGFR3
SCHEMBL17023164 0.82 FGFR3 (0.70) FGFR3
SCHEMBL17023055 0.81 FGFR3 (0.57) FGFR3
SCHEMBL17023115 0.81 FGFR3 (0.67) FGFR3
SCHEMBL17023051 0.80 FGFR3 (0.55) FGFR3
SCHEMBL17023047 0.79 FGFR3 (0.70) FGFR3
SCHEMBL4331503 0.79 FGFR3 (0.76) FGFR3
SCHEMBL17023113 0.79 FGFR3 (0.68) FGFR3
SCHEMBL17023136 0.79 FGFR3 (0.72) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-B1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2015-08-26 EP claimed